Octogena Pharmaceuticals Private Limited
About Octogena Pharmaceuticals Private Limited
Data last updated:
Octogena Pharmaceuticals Private Limited is a private limited company based in Solapur North, Maharashtra, India. It operates in the optical and photographic instruments segment of the manufacturing sector. It was incorporated on 09 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33208PN2018PTC179492. Its GSTIN is 27AACCO7990A1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Samreen Asif Savkar and Asif Savkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Solapur North, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.04 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹28,328 (net margin 4.7%) and EBITDA of ₹29,526 (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
Company details
Contact details
Octogena Pharmaceuticals Private Limited's registered office is in Solapur North, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressBlock No 2A Sirat Nagar, Civil Lines Kumthe Naka Solapur, Solapur North, Maharashtra, India – 413003
- IndustryManufacturing, Optical & Photographic Instruments, Manufacturing
To see the full contact details of Octogena Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Octogena Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Octogena Pharmaceuticals Private Limited, buy the company report.
Financials of Octogena Pharmaceuticals Private Limited
FY 2025 filings availableOctogena Pharmaceuticals Private Limited reported revenue of ₹6.04 Lakh (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 35% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29,526 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,328 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Octogena Pharmaceuticals Private Limited, buy the company report.
Board of directors of Octogena Pharmaceuticals Private Limited
Octogena Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samreen Asif Savkar | Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Asif Savkar | Director | 09 Oct 2018 | 8 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Octogena Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Octogena Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Octogena Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCO7990A1ZD | Maharashtra | Active | 05 Nov 2018 |
To see the full GST registrations and return filing status of Octogena Pharmaceuticals Private Limited, buy the company report.
Recent activity
Octogena Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Asif Savkar was appointed as Director on 09 Oct 2018.
Frequently asked questions
Octogena Pharmaceuticals is an active private limited company based in Solapur North, Maharashtra, India. The company works in optical and photographic instruments, within the manufacturing industry. It was incorporated on 09 October 2018 (8+ years old) and is registered under CIN U33208PN2018PTC179492.
Octogena Pharmaceuticals has 2 current directors:
- Samreen Asif Savkar - Director
- Asif Savkar - Director
The latest financial statements of Octogena Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Octogena Pharmaceuticals is 27AACCO7990A1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Octogena Pharmaceuticals is U33208PN2018PTC179492. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Octogena Pharmaceuticals was incorporated on 09 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Asif Savkar was appointed as Director on 09 Oct 2018. Samreen Asif Savkar was appointed as Director on 09 Oct 2018.
The registered office of Octogena Pharmaceuticals is at Block No 2A Sirat Nagar, Civil Lines Kumthe Naka Solapur, Solapur North, Maharashtra, India – 413003.
Octogena Pharmaceuticals operates in the manufacturing industry, in the optical and photographic instruments segment.
Octogena Pharmaceuticals can be reached at its registered office: Block No 2A Sirat Nagar, Civil Lines Kumthe Naka Solapur, Solapur North, Maharashtra, India – 413003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
